Alector
Alector Cuts 17% of Workforce Following Failure of AbbVie-Partnered Alzheimer’s Drug in Phase 2 Trial
Alector, layoffs, AbbVie, Alzheimer’s disease, phase 2 trial failure, biotech industry
Actionable Insights Powered by AI
Alector, layoffs, AbbVie, Alzheimer’s disease, phase 2 trial failure, biotech industry